SynthesisInternational health2026
Atopic dermatitis in Ethiopia: a systematic review and meta-analysis.
Synthesis in International health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite being a leading contributor to the global burden of skin disease there is no information on the national prevalence of atopic dermatitis in Ethiopia. Therefore, the purpose of this systematic review and meta-analysis was to estimate the pooled national prevalence of atopic dermatitis in Ethiopia. A computerized systematic search using multiple databases was performed in search of relevant English articles from the inception of the databases to 30 July 2023. It was done in accordance with the Preferred Reporting Items for Systematic review and Meta-Analysis (i.e. PRISMA) standard. R and R Studio software were used for statistical analysis. A random-effects model was used for calculating the pooled estimate of the prevalence of atopic dermatitis. Forest plots and tables were used to represent the data. We found 10 full-text observational studies with 25 920 participants suitable for the review after checking for inclusion and exclusion criteria. The overall pooled prevalence of atopic dermatitis in Ethiopia was 12.75% (95% CI 8.32 to 17.17%). The subgroup analysis found that the atopic dermatitis pooled prevalence was 7% (95% CI 3 to 10%), 17% (95% CI 4 to 30%) and 20% (95% CI 15 to 24%) in the Oromia region, Amhara region and Addis Ababa city administration, respectively. This study demonstrates that atopic dermatitis is highly prevalent in Ethiopia, affecting approximately one in eight individuals, with significant geographical variations. To effectively address this condition, it is crucial to implement awareness campaigns, prioritize specialized training for healthcare professionals, allocate resources to high-prevalence areas, establish a national registry for monitoring, develop community support programs and encourage further research, as there are currently few studies on the condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.